Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

Commercial Launch Initiated for Neonorm Dog, Jaguar Health's Non-Prescription Product for Support of Normal Stool Consistency and GI Fluid Balance in Dogs

$JAGXPress releaseAug 26, 2026, 9:00 AM ETRead the release

Jaguar Health initiated the commercial launch of Neonorm Dog, a plant-based, non-prescription product designed to support normal stool consistency and GI fluid balance in dogs. The launch extends the Neonorm franchise beyond production animals like foals and calves into the companion animal market, with availability expected soon on Amazon and Chewy.

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    JAGX: Commercial Launch Initiated for Neonorm Dog, Jaguar Health's Non-Prescription Product for Support of Normal Stool Consistency and GI Fluid Balance in Dogs — AI Analysis | Signal8